XLVIvsXLVETF Comparison
ETF 1
XLVI
State Street Health Care Select Sector SPDR Premium Income Fund
This fund is part of
Options Strategies
-0.49%
VS
State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) belongs to the Options Strategies segment. State Street Health Care Select Sector SPDR ETF (XLV) is part of the US Health Care segment. Both ETFs have the same top 2 sector exposures: Healthcare and Consumer Non-Cyclicals. XLVI is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.08% for XLV. XLVI is up 5.69% year-to-date (YTD) with +$14M in YTD flows. XLV performs better with 7.93% YTD performance, and +$583M in YTD flows. Run a side-by-side ETF comparison of XLVI and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLVI vs XLV performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLVI XLV | -3.75%-1.68% | +3.97%+8.85% | +5.69%+7.93% | +16.54%+22.72% | n/a+30.97% | n/a+34.86% |
| Flows | XLVI XLV | +$4M-$296M | +$11M+$805M | +$14M+$583M | +$25M+$1.66B | --$5.56B | -+$2.10B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLVI XLV | +11.87%+19.48% | +11.09%+16.26% | n/a+14.74% | n/a+15.18% |
| Max drawdown | XLVI XLV | -4.77%-5.68% | -8.21%-10.51% | n/a-17.05% | n/a-17.05% |
| Max drawdown duration | XLVI XLV | 16d22d | 115d116d | n/a444d | n/a444d |
Trading data
XLVI | XLV | |
Last sale 9/11/2026 at 1:30 PM | $25.71 | $165.36 |
| Previous close 09/10/2026 | $25.73 | $165.66 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XLVI
is actively managed and doesn’t replicate an indexXLVI | XLV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
XLVI | XLV | |
|---|---|---|
| Last price | $25.71 | $165.36 |
| 1D performance | -0.07% | -0.18% |
| AuM | $25.47 M | $42.99 B |
| E/R | 0.35% | 0.08% |
Characteristics
XLVI | XLV | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | State Street Investment Management | State Street Investment Management |
| Benchmark | - | S&P Health Care Select Sector Index |
| N° of holdings | 59 | 59 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | July 30, 2025 | December 16, 1998 |
| ESG | No | No |
Advertisement
Exposure
Countries
XLVI
USA
97.34%
Other
2.66%
XLV
USA
97.53%
Other
2.47%
Sectors
XLVI
Healthcare
97.32%
Other
2.68%
XLV
Healthcare
97.51%
Other
2.49%
Advertisement
Diversification
XLVI
Total weight of top 15 holdings out of 15
71.63%
XLV
Total weight of top 15 holdings out of 15
71.77%
Top 15 holdings
Data as of July 31, 2026
XLVI
Eli Lilly & Co.
15.45%
Johnson & Johnson
10.49%
AbbVie, Inc.
7.54%
UnitedHealth Group, Inc.
6.40%
Merck & Co., Inc.
5.47%
Thermo Fisher Scientific, Inc.
3.63%
Amgen, Inc.
3.53%
Abbott Laboratories
3.13%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.42%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
XLV
Eli Lilly & Co.
15.48%
Johnson & Johnson
10.51%
AbbVie, Inc.
7.55%
UnitedHealth Group, Inc.
6.41%
Merck & Co., Inc.
5.48%
Thermo Fisher Scientific, Inc.
3.64%
Amgen, Inc.
3.54%
Abbott Laboratories
3.14%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.43%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
Frequently asked questions about XLVI and XLV
How have the XLVI and XLV ETFs performed in 2026?
As of September 10, 2026, XLVI is up 5.69% year-to-date (YTD), while XLV has returned 7.93%. That puts XLV better performer ahead so far this year.
Which ETF is attracting more investor money: XLVI or XLV?
Year-to-date, the XLVI ETF saw +$14M in flows, compared to +$583M for XLV.
Which ETF is more volatile: XLVI or XLV?
Over the past year, XLVI had a volatility of 11.09%, while XLV experienced 16.26%.
Which ETF is bigger: XLVI or XLV?
As of September 10, 2026, XLVI holds $25.47 M in assets under management (AUM), while XLV manages $42.99 B.
What sectors do the XLVI and XLV ETFs invest in?
XLVI leans toward sectors like Healthcare. Meanwhile, XLV focuses on Healthcare.
What are the top holdings of the XLVI ETF and XLV ETF?
XLVI top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. XLV holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: XLVI or XLV?
XLVI holds 59 securities with 71.63% of its assets in the top 15. XLV has 59 securities and a top 15 weight of 71.77%.
Advertisement
Latest news about XLVI & XLV
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
